Report
John Likos
EUR 100.00 For Business Accounts Only

Transfer of Analyst Coverage on Sonic Healthcare; AUD 25.50 FVE Unchanged

We have transferred analyst coverage of narrow-moat-rated Sonic Healthcare. We maintain our AUD 25.50 fair value estimate, although we make some minor adjustments to our forecasts. These include slight downward adjustments to our gross margin assumptions and a slight paring-back of our revenue growth assumptions for the Australian pathology business. In combination, the changes do not alter our fair value estimate, highlighting their minor nature.
As one of the two market leaders, Sonic generate...
Underlying
Sonic Healthcare Limited

Sonic Healthcare is involved in the provision of medical diagnostic services and the provision of administrative services and facilities to medical practitioners. Co. provides specialized pathology/clinical laboratory and diagnostic imaging services to clinicians, hospitals, community health services, and their patients. Co.'s segments are comprised of: Laboratory, which provides Pathology/clinical laboratory services in Australia, New Zealand, the U.K., the U.S., Germany, Switzerland, Belgium and Ireland; Imaging, which provides diagnostic imaging services in Australia; and Other, which Includes medical center operations and occupational health services.

Provider
Morningstar
Morningstar

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.

Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.

We have operations in 27 countries.

Analysts
John Likos

Other Reports on these Companies
Other Reports from Morningstar

ResearchPool Subscriptions

Get the most out of your insights

Get in touch